Documentos relacionados

1. ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
2. The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study.
3. Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement.
4. Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses.
5. Mycophenolate Mofetil with Steroid, a Reasonable Alternative to Current First-line Therapy, for Idiopathic Membranous Nephropathy in Resource-constrained Settings: A Randomized, Open-label Study.
6. ANCA associated glomerulonephritis in a patient with mixed connective tissue disease.
7. ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study.
8. Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
9. Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement
10. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.